{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:05:15Z","timestamp":1791641115843,"version":"4.3.4"},"publisher-location":"Cham","reference-count":160,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032231710","type":"print"},{"value":"9783032231727","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-23172-7_3","type":"book-chapter","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:12:25Z","timestamp":1777597945000},"page":"29-57","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Drug Design of Carbonic Anhydrase Inhibitors"],"prefix":"10.1007","author":[{"given":"Neera","family":"Raghav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Paoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"3_CR1","doi-asserted-by":"publisher","first-page":"7376","DOI":"10.1002\/slct.202101854","volume":"6","author":"M Abas","year":"2021","unstructured":"Abas M, Nazir Y, Ashraf Z, Iqbal Z, Raza H, Hassan M, Jabeen E, Bais A (2021) A practical method of N-methylpyrrole disulfonamides synthesis: computational studies, carbonic anhydrase inhibition and electrochemical DNA binding investigations. ChemistrySelect 6:7376\u20137383","journal-title":"ChemistrySelect"},{"issue":"1","key":"3_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/ph19010151","volume":"19","author":"M Abdoli","year":"2026","unstructured":"Abdoli M, Angeli A, Bonardi A, Gratteri P, Jackevica L, Sizovs A, Supuran CT, \u017dalubovskis R (2026) Investigation on N-Aryl-2-(4-sulfamoylphenyl)hydrazine-1-carbothioamide as human carbonic anhydrases inhibitors. Pharmaceuticals 19(1):151","journal-title":"Pharmaceuticals"},{"key":"3_CR3","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.bioorg.2019.04.002","volume":"87","author":"MF Abo-Ashour","year":"2019","unstructured":"Abo-Ashour MF, Eldehna WM, Nocentini A, Ibrahim HS, Bua S, Abdel-Aziz HA, Abou-Seri SM, Supuran CT (2019) Novel synthesized SLC-0111 thiazole and thiadiazole analogues: determination of their carbonic anhydrase inhibitory activity and molecular modeling studies. Bioorg Chem 87:794\u2013802","journal-title":"Bioorg Chem"},{"key":"3_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.114004","volume":"228","author":"HT Abdel-Mohsen","year":"2022","unstructured":"Abdel-Mohsen HT, El Kerdawy AM, Omar MA, Petreni A, Allam RM, El Diwani HI, Supuran CT (2022) Application of the dual-tail approach for the design and synthesis of novel thiopyrimidine-benzenesulfonamide hybrids as selective carbonic anhydrase inhibitors. Eur J Med Chem 228:114004","journal-title":"Eur J Med Chem"},{"key":"3_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115805","volume":"261","author":"RF Ahmed","year":"2023","unstructured":"Ahmed RF, Mahmoud WR, Abdelgawad NM, Fouad MA, Said MF (2023) Exploring novel anticancer pyrazole benzenesulfonamides featuring tail approach strategy as carbonic anhydrase inhibitors. Eur J Med Chem 261:115805","journal-title":"Eur J Med Chem"},{"issue":"28","key":"3_CR6","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.2174\/0115680266373008250723064558","volume":"25","author":"S Akocak","year":"2025","unstructured":"Akocak S, Lolak N, Ammara A, G\u00fcler OO, Supuran CT (2025) Exploring the carbonic anhydrase activation properties of 4-arylazo-3, 5-diamino-1H-pyrazoles against hCA I, II, IV, and VII isoenzymes. Curr Top Med Chem 25(28):3281\u20133290","journal-title":"Curr Top Med Chem"},{"issue":"8","key":"3_CR7","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1021\/cr200176r","volume":"112","author":"V Alterio","year":"2012","unstructured":"Alterio V, Di Fiore A, D\u2019Ambrosio K, Supuran CT, De Simone G (2012) Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev 112(8):4421\u20134468","journal-title":"Chem Rev"},{"issue":"80","key":"3_CR8","doi-asserted-by":"publisher","first-page":"11983","DOI":"10.1039\/C6CC06399C","volume":"52","author":"V Alterio","year":"2016","unstructured":"Alterio V, Cadoni R, Esposito D, Vullo D, Di Fiore A, Monti SM, Caporale A, Ruvo M, Sechi M, Dumy P, Supuran CT, De Simone G, Winum JY (2016) Benzoxaborole as a new chemotype for carbonic anhydrase inhibition. Chem Commun (Camb) 52(80):11983\u201311986","journal-title":"Chem Commun (Camb)"},{"issue":"12","key":"3_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.70177","volume":"358","author":"A Ammara","year":"2025","unstructured":"Ammara A, Giovannuzzi S, Luca VD, Capasso C, Nocentini A, Supuran CT, Gratteri P (2025) Tetrazole derivatives as multiclass inhibitors of bacterial carbonic anhydrases. Arch Pharm 358(12):e70177","journal-title":"Arch Pharm"},{"issue":"48","key":"3_CR10","doi-asserted-by":"publisher","first-page":"11353","DOI":"10.1039\/C6OB02299E","volume":"14","author":"A Angeli","year":"2016","unstructured":"Angeli A, Peat TS, Bartolucci G, Nocentini A, Supuran CT, Carta F (2016) Intramolecular oxidative deselenization of acylselenoureas: a facile synthesis of benzoxazole amides and carbonic anhydrase inhibitors. Org Biomol Chem 14(48):11353\u201311356","journal-title":"Org Biomol Chem"},{"issue":"9","key":"3_CR11","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1021\/acsmedchemlett.7b00280","volume":"8","author":"A Angeli","year":"2017","unstructured":"Angeli A, Tanini D, Peat TS, Di Cesare Mannelli L, Bartolucci G, Capperucci A, Ghelardini C, Supuran CT, Carta F (2017) Discovery of new selenoureido analogues of 4-(4-fluorophenylureido)benzenesulfonamide as carbonic anhydrase inhibitors. ACS Med Chem Lett 8(9):963\u2013968","journal-title":"ACS Med Chem Lett"},{"issue":"7","key":"3_CR12","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.3390\/molecules28073220","volume":"28","author":"A Angeli","year":"2023","unstructured":"Angeli A, Paoletti N, Supuran CT (2023) Five-membered heterocyclic sulfonamides as carbonic anhydrase inhibitors. Molecules 28(7):3220","journal-title":"Molecules"},{"issue":"2","key":"3_CR13","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1021\/acs.jmedchem.2c01911","volume":"66","author":"A Angeli","year":"2023","unstructured":"Angeli A, Micheli L, Carta F, Ferraroni M, Pirali T, Fernandez Carvajal A, Ferrer Montiel A, Di Cesare Mannelli L, Ghelardini C, Supuran CT (2023) First-in-class dual hybrid carbonic anhydrase inhibitors and transient receptor potential vanilloid 1 agonists revert oxaliplatin-induced neuropathy. J Med Chem 66(2):1616\u20131633","journal-title":"J Med Chem"},{"issue":"4","key":"3_CR14","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1021\/acs.jmedchem.3c02254","volume":"67","author":"A Angeli","year":"2024","unstructured":"Angeli A, Chelli I, Lucarini L, Sgambellone S, Marri S, Villano S, Ferraroni M, De Luca V, Capasso C, Carta F, Supuran CT (2024) Novel carbonic anhydrase inhibitors with dual-tail core sulfonamide show potent and lasting effects for glaucoma therapy. J Med Chem 67(4):3066\u20133089","journal-title":"J Med Chem"},{"issue":"3","key":"3_CR15","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","volume":"20","author":"AG Atanasov","year":"2021","unstructured":"Atanasov AG, Zotchev SB, Dirsch VM, Supuran CT (2021) Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov 20(3):200\u2013216","journal-title":"Nat Rev Drug Discov"},{"issue":"24","key":"3_CR16","doi-asserted-by":"publisher","first-page":"9287","DOI":"10.1021\/jo901924m","volume":"74","author":"K Bahrami","year":"2009","unstructured":"Bahrami K, Khodaei MM, Soheilizad M (2009) Direct conversion of thiols to sulfonyl chlorides and sulfonamides. J Org Chem 74(24):9287\u20139291","journal-title":"J Org Chem"},{"issue":"6","key":"3_CR17","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3109\/14756360903571685","volume":"25","author":"L Baranauskien\u0117","year":"2010","unstructured":"Baranauskien\u0117 L, Hilvo M, Matulien\u0117 J, Golovenko D, Manakova E, Dudutien\u0117 V, Michailovien\u0117 V, Torresan J, Jachno J, Parkkila S, Maresca A, Supuran CT, Gra\u017eulis S, Matulis D (2010) Inhibition and binding studies of carbonic anhydrase isozymes I, II and IX with benzimidazo[1,2-c][1,2,3]thiadiazole-7-sulfonamides. J Enzyme Inhib Med Chem 25(6):863\u2013870","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"8","key":"3_CR18","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1021\/jm00140a009","volume":"24","author":"IT Barnish","year":"1981","unstructured":"Barnish IT, Cross PE, Dickinson RP, Parry MJ, Randall MJ (1981) Cerebrovasodilatation through selective inhibition of the enzyme carbonic anhydrase. 3. 5-(Arylthio)-, 5-(arylsulfinyl)-, and 5-(arylsulfonyl)thiophene-2-sulfonamides. J Med Chem 24(8):959\u2013964","journal-title":"J Med Chem"},{"issue":"7","key":"3_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202400073","volume":"357","author":"A Bendi","year":"2024","unstructured":"Bendi A, Taruna, Rajni, Kataria S, Singh L, Kennedy J, Supuran CT, Raghav N (2024) Chemistry of heterocycles as carbonic anhydrase inhibitors: a pathway to novel research in medicinal chemistry review. Arch Der Pharm 357(7):e2400073","journal-title":"Arch Der Pharm"},{"issue":"1","key":"3_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/antiox10010056","volume":"10","author":"E Berrino","year":"2021","unstructured":"Berrino E, Carradori S, Angeli A, Carta F, Supuran CT, Guglielmi P, Coletti C, Paciotti R, Schweikl H, Maestrelli F, Cerbai E, Gallorini M (2021) Dual carbonic anhydrase IX\/XII inhibitors and carbon monoxide releasing molecules modulate LPS-mediated inflammation in mouse macrophages. Antioxidants (Basel) 10(1):56","journal-title":"Antioxidants (Basel)"},{"issue":"3","key":"3_CR21","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1021\/acs.jmedchem.2c01706","volume":"66","author":"E Berrino","year":"2023","unstructured":"Berrino E, Micheli L, Carradori S, Di Cesare Mannelli L, Guglielmi P, De Luca A, Carta F, Ghelardini C, Secci D, Supuran CT (2023) Novel insights on CAI-CORM hybrids: evaluation of the CO releasing properties and pain-relieving activity of differently substituted coumarins for the treatment of rheumatoid arthritis. J Med Chem 66(3):1892\u20131908","journal-title":"J Med Chem"},{"key":"3_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejmech.2018.01.033","volume":"146","author":"A Bonardi","year":"2018","unstructured":"Bonardi A, Falsini M, Catarzi D, Varano F, Di Cesare Mannelli L, Tenci B, Ghelardini C, Angeli A, Supuran CT, Colotta V (2018) Structural investigations on coumarins leading to chromeno[4,3-c]pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: new scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII. Eur J Med Chem 146:47\u201359","journal-title":"Eur J Med Chem"},{"issue":"13","key":"3_CR23","doi-asserted-by":"publisher","first-page":"7422","DOI":"10.1021\/acs.jmedchem.0c00733","volume":"63","author":"A Bonardi","year":"2020","unstructured":"Bonardi A, Nocentini A, Bua S, Combs J, Lomelino C, Andring J, Lucarini L, Sgambellone S, Masini E, McKenna R, Gratteri P, Supuran CT (2020) Sulfonamide inhibitors of human carbonic anhydrases designed through a three-tails approach: improving ligand\/isoform matching and selectivity of action. J Med Chem 63(13):7422\u20137444","journal-title":"J Med Chem"},{"issue":"1","key":"3_CR24","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1080\/14756366.2022.2053526","volume":"37","author":"A Bonardi","year":"2022","unstructured":"Bonardi A, Bua S, Combs J, Lomelino C, Andring J, Osman SM, Toti A, Di Cesare Mannelli L, Gratteri P, Ghelardini C, McKenna R, Nocentini A, Supuran CT (2022) The three-tails approach as a new strategy to improve selectivity of action of sulfonamide inhibitors against tumour-associated carbonic anhydrase IX and XII. J Enzyme Inhib Med Chem 37(1):930\u2013939","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"11","key":"3_CR25","doi-asserted-by":"publisher","first-page":"9613","DOI":"10.1021\/acs.jmedchem.4c00740","volume":"67","author":"A Bonardi","year":"2024","unstructured":"Bonardi A, Nocentini A, Giovannuzzi S, Paoletti N, Ammara A, Bua S, Abutaleb NS, Abdelsattar AS, Capasso C, Gratteri P, Flaherty DP, Seleem MN, Supuran CT (2024) Development of penicillin-based carbonic anhydrase inhibitors targeting multidrug-resistant Neisseria gonorrhoeae. J Med Chem 67(11):9613\u20139627","journal-title":"J Med Chem"},{"issue":"12","key":"3_CR26","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.3390\/molecules22122072","volume":"22","author":"S Bouasla","year":"2017","unstructured":"Bouasla S, Amaro-Gahete J, Esquivel D, L\u00f3pez MI, Jim\u00e9nez-Sanchidri\u00e1n C, Teguiche M, Romero-Salguero FJ (2017) Coumarin derivatives solvent-free synthesis under microwave irradiation over heterogeneous solid catalysts. Molecules 22(12):2072","journal-title":"Molecules"},{"key":"3_CR27","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.bmc.2013.11.016","volume":"22","author":"M Bozdag","year":"2014","unstructured":"Bozdag M, Ferraroni M, Nuti E, Vullo D, Rossello A, Carta F, Scozzafava A, Supuran CT (2014) Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studies. Bioorg Med Chem 22:334\u2013340","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"3_CR28","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1080\/14756366.2017.1337759","volume":"32","author":"M Bozdag","year":"2017","unstructured":"Bozdag M, Bua S, Osman SM, AlOthman Z, Supuran CT (2017) Carbonic anhydrase I, II, IV and IX inhibition with a series of 7-amino-3,4-dihydroquinolin-2(1H)-one derivatives. J Enzyme Inhib Med Chem 32(1):885\u2013892","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"1","key":"3_CR29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1021\/acs.jmedchem.9b01669","volume":"63","author":"S Bua","year":"2020","unstructured":"Bua S, Lomelino C, Murray AB, Osman SM, AlOthman ZA, Bozdag M, Abdel-Aziz HA, Eldehna WM, McKenna R, Nocentini A, Supuran CT (2020) \u201cA sweet combination\u201d: developing saccharin and acesulfame K structures for selectively targeting the tumor-associated carbonic anhydrases IX and XII. J Med Chem 63(1):321\u2013333","journal-title":"J Med Chem"},{"issue":"15","key":"3_CR30","doi-asserted-by":"publisher","first-page":"5511","DOI":"10.1021\/jm1003667","volume":"53","author":"F Carta","year":"2010","unstructured":"Carta F, Temperini C, Innocenti A, Scozzafava A, Kaila K, Supuran CT (2010) Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule. J Med Chem 53(15):5511\u20135522","journal-title":"J Med Chem"},{"key":"3_CR31","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1016\/j.bmc.2015.02.027","volume":"23","author":"F Carta","year":"2015","unstructured":"Carta F, Di Cesare Mannelli L, Pinard M, Ghelardini C, Scozzafava A, McKenna R, Supuran CT (2015) A class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects. Bioorg Med Chem 23:1828\u20131840","journal-title":"Bioorg Med Chem"},{"key":"3_CR32","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1021\/acs.jmedchem.7b00183","volume":"60","author":"F Carta","year":"2017","unstructured":"Carta F, Birkmann A, Pfaff T, Buschmann H, Schwab W, Zimmermann H, Maresca A, Supuran CT (2017) Lead development of thiazolylsulfonamides with carbonic anhydrase inhibitory action. J Med Chem 60:3154\u20133164","journal-title":"J Med Chem"},{"key":"3_CR33","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3109\/21691401.2013.769448","volume":"42","author":"F Celik","year":"2014","unstructured":"Celik F, Arslan M, Kaya MO, Yavuz E, Gencer N, Arslan O (2014) Synthesis and carbonic anhydrase inhibitory properties of tetrazole- and oxadiazole substituted 1,4-dihydropyrimidinone compounds. Artif Cells Nanomed Biotechnol 42:58","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"13","key":"3_CR34","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1016\/j.bmc.2016.04.052","volume":"24","author":"N Chandak","year":"2016","unstructured":"Chandak N, Ceruso M, Supuran CT, Sharma PK (2016) Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XII. Bioorg Med Chem 24(13):2882\u20132886","journal-title":"Bioorg Med Chem"},{"key":"3_CR35","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1016\/j.bmc.2014.06.016","volume":"22","author":"K Chegaev","year":"2014","unstructured":"Chegaev K, Lazzarato L, Tamboli Y, Boschi D, Blangetti M, Scozzafava A, Carta F, Masini E, Fruttero R, Supuran C, Gasco A (2014) Furazan and furoxan sulfonamides are strong \u03b1-carbonic anhydrase inhibitors and potential antiglaucoma agents. Bioorg Med Chem 22:3913\u20133921","journal-title":"Bioorg Med Chem"},{"key":"3_CR36","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ejmech.2018.04.002","volume":"151","author":"N Chiaramonte","year":"2018","unstructured":"Chiaramonte N, Bua S, Ferraroni M, Nocentini A, Bonardi A, Bartolucci G, Durante M, Lucarini L, Chiapponi D, Dei S, Manetti D, Teodori E, Gratteri P, Masini E, Supuran CT, Romanelli MN (2018) 2-Benzylpiperazine: a new scaffold for potent human carbonic anhydrase inhibitors. Eur J Med Chem 151:363\u2013375","journal-title":"Eur J Med Chem"},{"key":"3_CR37","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/S0014-827X(99)00096-8","volume":"54","author":"EE Chuf\u00e1n","year":"1999","unstructured":"Chuf\u00e1n EE, Pedregosa JC, Baldini ON, Bruno-Blanch L (1999) Anticonvulsant activity of analogues of acetazolamide. Farmaco 54:838\u2013841","journal-title":"Farmaco"},{"issue":"5","key":"3_CR38","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.bmcl.2009.01.038","volume":"19","author":"L Crocetti","year":"2009","unstructured":"Crocetti L, Maresca A, Temperini C, Hall RA, Scozzafava A, M\u00fchlschlegel FA, Supuran CT (2009) A thiabendazole sulfonamide shows potent inhibitory activity against mammalian and nematode alpha-carbonic anhydrases. Bioorg Med Chem Lett 19(5):1371\u20131375","journal-title":"Bioorg Med Chem Lett"},{"issue":"85","key":"3_CR39","doi-asserted-by":"publisher","first-page":"13033","DOI":"10.1039\/D0CC05172A","volume":"56","author":"K D\u2019Ambrosio","year":"2020","unstructured":"D\u2019Ambrosio K, Carradori S, Cesa S, Angeli A, Monti SM, Supuran CT, De Simone G (2020) Catechols: a new class of carbonic anhydrase inhibitors. Chem Commun (Camb) 56(85):13033\u201313036","journal-title":"Chem Commun (Camb)"},{"key":"3_CR40","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/S0021-9258(19)51331-X","volume":"158","author":"HW Davenport","year":"1945","unstructured":"Davenport HW (1945) The inhibition of carbonic anhydrase by thiophene-2-sulfonamide and sulfanilamide. J Biol Chem 158:567","journal-title":"J Biol Chem"},{"issue":"6","key":"3_CR41","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/j.bmc.2012.07.021","volume":"21","author":"RA Davis","year":"2013","unstructured":"Davis RA, Vullo D, Maresca A, Supuran CT, Poulsen SA (2013) Natural product coumarins that inhibit human carbonic anhydrases. Bioorg Med Chem 21(6):1539\u20131543","journal-title":"Bioorg Med Chem"},{"key":"3_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.118304","volume":"302","author":"MAZ El-Attar","year":"2026","unstructured":"El-Attar MAZ, Afifi OS, Ismail A, Kamel YN, Yassin HA, Nomeir HM, Nematalla HA, Angeli A, Labib HF, Eldehna WM, Supuran CT, Belal ASF, Elzahhar PA, Hassan NW (2026) Click-modifiable isatin hydrazones as COX-2, VEGFR-2, and carbonic anhydrase inhibitors: a multi-target approach to cancer therapy. Eur J Med Chem 302:118304","journal-title":"Eur J Med Chem"},{"issue":"12","key":"3_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2023.101866","volume":"31","author":"AS El-Azab","year":"2023","unstructured":"El-Azab AS, Abdel-Aziz AAM, Bua S, Nocentini A, Bakheit AH, Alkahtani HM, Hefnawy MM, Supuran CT (2023) Design, synthesis, and carbonic anhydrase inhibition activities of Schiff bases incorporating benzenesulfonamide scaffold: molecular docking application. Saudi Pharm J 31(12):101866","journal-title":"Saudi Pharm J"},{"key":"3_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113486","volume":"221","author":"AH Eldeeb","year":"2021","unstructured":"Eldeeb AH, Abo-Ashour MF, Angeli A, Bonardi A, Lasheen DS, Elrazaz EZ, Nocentini A, Gratteri P, Abdel-Aziz HA, Supuran CT (2021) Novel benzenesulfonamides aryl and arylsulfone conjugates adopting tail\/dual-tail approaches: synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies. Eur J Med Chem 221:113486","journal-title":"Eur J Med Chem"},{"key":"3_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.103102","volume":"90","author":"WM Eldehna","year":"2019","unstructured":"Eldehna WM, Abdelrahman MA, Nocentini A, Bua S, Al-Rashood ST, Hassan GS, Bonardi A, Almehizia AA, Alkahtani HM, Alharbi A, Gratteri P, Supuran CT (2019) Synthesis, biological evaluation and in silico studies with 4-benzylidene-2-phenyl-5(4H)-imidazolone-based benzenesulfonamides as novel selective carbonic anhydrase IX inhibitors endowed with anticancer activity. Bioorg Chem 90:103102","journal-title":"Bioorg Chem"},{"key":"3_CR46","doi-asserted-by":"publisher","unstructured":"Eldehna WM, Elsayed ZM, Elnagar MR, Ammara A, Elkotamy MS, Monir R, Nocentini A, Al-Sanea MM, Supuran CT, Tawfik HO, Abdel-Aziz HA, Negmeldin AT (2026) Discovery of enaminone-linked benzofuran derivatives as dual VEGFR-2\/hCA IX inhibitors exhibiting hypoxia-mediated chemosensitization. RSC Med Chem (in press). https:\/\/doi.org\/10.1039\/d5md01043h","DOI":"10.1039\/d5md01043h"},{"key":"3_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.109071","volume":"166","author":"WM Eldehna","year":"2025","unstructured":"Eldehna WM, Elnagar MR, Giovannuzzi S, Tayel A, Abdulla MH, Alhassan NS, Shaldam MA, Nocentini A, Supuran CT, Tawfik HO (2025) Identification of isatin-triazole-benzenesulfonamide hybrids as dual hCA IX\/XII and c-met inhibitors with hypoxia-mediated chemo-sensitizing activity. Bioorg Chem 166:109071","journal-title":"Bioorg Chem"},{"issue":"24","key":"3_CR48","doi-asserted-by":"publisher","first-page":"26280","DOI":"10.1021\/acs.jmedchem.5c02403","volume":"68","author":"MM Eldesouki","year":"2025","unstructured":"Eldesouki MM, Alkabbani MA, Taghour MS, Ammara A, Elimam DM, Elwan A, Monir R, Afarinkia K, Nocentini A, Supuran CT, Tawfik HO, Eldehna WM (2025) Identification of benzenesulfonamide-containing thiazolidine-2, 4-Dione derivatives as novel carbonic anhydrase II and VII inhibitors with anti-epileptic activity. J Med Chem 68(24):26280\u201326297","journal-title":"J Med Chem"},{"issue":"1","key":"3_CR49","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1080\/14756366.2018.1513927","volume":"33","author":"MG El-Gazzar","year":"2018","unstructured":"El-Gazzar MG, Nafie NH, Nocentini A, Ghorab MM, Heiba HI, Supuran CT (2018) Carbonic anhydrase inhibition with a series of novel benzenesulfonamide-triazole conjugates. J Enzyme Inhib Med Chem 33(1):1565\u20131574","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"6","key":"3_CR50","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1021\/acs.jmedchem.9b02090","volume":"63","author":"M Fares","year":"2020","unstructured":"Fares M, Eldehna WM, Bua S, Lanzi C, Lucarini L, Masini E, Peat TS, Abdel-Aziz HA, Nocentini A, Keller PA, Supuran CT (2020) Discovery of potent dual-tailed benzenesulfonamide inhibitors of human carbonic anhydrases implicated in glaucoma and in vivo profiling of their intraocular pressure-lowering action. J Med Chem 63(6):3317\u20133326","journal-title":"J Med Chem"},{"key":"3_CR51","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1016\/j.bmc.2017.06.054","volume":"25","author":"M Ferraroni","year":"2017","unstructured":"Ferraroni M, Lucarini L, Masini E, Korsakov M, Scozzafava A, Supuran CT, Krasavin M (2017) 1,3-Oxazole-based selective picomolar inhibitors of cytosolic human carbonic anhydrase II alleviate ocular hypertension in rabbits: potency is supported by X-ray crystallography of two leads. Bioorg Med Chem 25:4560\u20134565","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"3_CR52","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1080\/14756366.2020.1713114","volume":"35","author":"B Fois","year":"2020","unstructured":"Fois B, Distinto S, Meleddu R, Deplano S, Maccioni E, Floris C, Rosa A, Nieddu M, Caboni P, Sissi C, Angeli A, Supuran CT, Cottiglia F (2020) Coumarins from Magydaris pastinacea as inhibitors of the tumour-associated carbonic anhydrases IX and XII: isolation, biological studies and in silico evaluation. J Enzyme Inhib Med Chem 35(1):539\u2013548","journal-title":"J Enzyme Inhib Med Chem"},{"key":"3_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116434","volume":"271","author":"MA Gamal","year":"2024","unstructured":"Gamal MA, Fahim SH, Giovannuzzi S, Fouad MA, Bonardi A, Gratteri P, Supuran CT, Hassan GS (2024) Probing benzenesulfonamide-thiazolidinone hybrids as multitarget directed ligands for efficient control of type 2 diabetes mellitus through targeting the enzymes \u03b1-glucosidase and carbonic anhydrase II. Eur J Med Chem 271:116434","journal-title":"Eur J Med Chem"},{"issue":"1","key":"3_CR54","doi-asserted-by":"publisher","first-page":"2202360","DOI":"10.1080\/14756366.2023.2202360","volume":"38","author":"S Giovannuzzi","year":"2023","unstructured":"Giovannuzzi S, Bonardi A, Gratteri P, Nocentini A, Supuran CT (2023) Discovery of the first-in-class potent and isoform-selective human carbonic anhydrase III inhibitors. J Enzyme Inhib Med Chem 38(1):2202360","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"12","key":"3_CR55","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1080\/13543776.2025.2576513","volume":"35","author":"S Giovannuzzi","year":"2025","unstructured":"Giovannuzzi S, Nocentini A, Supuran CT, Winum JY (2025) Therapeutic applications of benzoxaborole compounds: a patent and literature analysis (2019\u20132024). Expert Opin Ther Pat 35(12):1241\u20131261","journal-title":"Expert Opin Ther Pat"},{"issue":"5","key":"3_CR56","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1021\/acs.jmedchem.4c00045","volume":"67","author":"S Giovannuzzi","year":"2024","unstructured":"Giovannuzzi S, Chavarria D, Provensi G, Leri M, Bucciantini M, Carradori S, Bonardi A, Gratteri P, Borges F, Nocentini A, Supuran CT (2024) Dual inhibitors of brain carbonic anhydrases and monoamine oxidase-B efficiently protect against amyloid-\u03b2-induced neuronal toxicity, oxidative stress, and mitochondrial dysfunction. J Med Chem 67(5):4170\u20134193","journal-title":"J Med Chem"},{"issue":"9","key":"3_CR57","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.tips.2025.07.002","volume":"46","author":"S Giovannuzzi","year":"2025","unstructured":"Giovannuzzi S, Supuran CT (2025) Human carbonic anhydrase modulators: the past, present, and future. Trends Pharmacol Sci 46(9):836\u2013847","journal-title":"Trends Pharmacol Sci"},{"issue":"10","key":"3_CR58","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.1016\/j.bmc.2009.03.066","volume":"17","author":"R Gitto","year":"2009","unstructured":"Gitto R, Ferro S, Agnello S, De Luca L, De Sarro G, Russo E, Vullo D, Supuran CT, Chimirri A (2009) Synthesis and evaluation of pharmacological profile of 1-aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamides. Bioorg Med Chem 17(10):3659\u20133664","journal-title":"Bioorg Med Chem"},{"key":"3_CR59","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1021\/jm00164a045","volume":"33","author":"SL Graham","year":"1990","unstructured":"Graham SL, Hoffman JM, Gautheron P, Michelson SR, Scholz TH, Schwam H, Shepard KL, Smith AM, Smith RL, Sondey JM et al (1990) Topically active carbonic anhydrase inhibitors. 3. Benzofuran- and indole-2-sulfonamides. J Med Chem 33:749\u2013754","journal-title":"J Med Chem"},{"issue":"5","key":"3_CR60","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.bmc.2014.01.043","volume":"22","author":"A Grandane","year":"2014","unstructured":"Grandane A, Tanc M, Zalubovskis R, Supuran CT (2014) Synthesis of 6-tetrazolyl-substituted sulfocoumarins acting as highly potent and selective inhibitors of the tumor-associated carbonic anhydrase isoforms IX and XII. Bioorg Med Chem 22(5):1522\u20131528","journal-title":"Bioorg Med Chem"},{"issue":"5","key":"3_CR61","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.bmcl.2014.01.076","volume":"24","author":"A Grandane","year":"2014","unstructured":"Grandane A, Tanc M, Zalubovskis R, Supuran CT (2014) 6-Triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrases IX and XII. Bioorg Med Chem Lett 24(5):1256\u20131260","journal-title":"Bioorg Med Chem Lett"},{"issue":"7","key":"3_CR62","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.bmc.2015.02.023","volume":"23","author":"A Grandane","year":"2015","unstructured":"Grandane A, Tanc M, \u017dalubovskis R, Supuran CT (2015) Synthesis of 6-aryl-substituted sulfocoumarins and investigation of their carbonic anhydrase inhibitory action. Bioorg Med Chem 23(7):1430\u20131436","journal-title":"Bioorg Med Chem"},{"issue":"9","key":"3_CR63","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1021\/acs.jmedchem.5b00523","volume":"58","author":"A Grandane","year":"2015","unstructured":"Grandane A, Tanc M, Di Cesare Mannelli L, Carta F, Ghelardini C, \u017dalubovskis R, Supuran CT (2015) 6-Substituted sulfocoumarins are selective carbonic anhydrase IX and XII inhibitors with significant cytotoxicity against colorectal cancer cells. J Med Chem 58(9):3975\u20133983","journal-title":"J Med Chem"},{"issue":"1","key":"3_CR64","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1080\/14756366.2017.1368019","volume":"32","author":"\u0130 Gul\u00e7in","year":"2017","unstructured":"Gul\u00e7in \u0130, Abbasova M, Taslimi P, Huyut Z, Safarova L, Sujayev A, Farzaliyev V, Beydemir \u015e, Alwasel SH, Supuran CT (2017) Synthesis and biological evaluation of aminomethyl and alkoxymethyl derivatives as carbonic anhydrase, acetylcholinesterase and butyrylcholinesterase inhibitors. J Enzyme Inhib Med Chem 32(1):1174\u20131182","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"14","key":"3_CR65","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.1016\/j.bmc.2009.06.006","volume":"17","author":"O G\u00fczel","year":"2009","unstructured":"G\u00fczel O, Innocenti A, Scozzafava A, Salman A, Supuran CT (2009) Carbonic anhydrase inhibitors. Aromatic\/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB. Bioorg Med Chem 17(14):4894\u20134899","journal-title":"Bioorg Med Chem"},{"key":"3_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmech.2017.03.023","volume":"132","author":"Z Hou","year":"2017","unstructured":"Hou Z, Lin B, Bao Y, Yan HN, Zhang M, Chang XW, Zhang XX, Wang ZJ, Wei GF, Cheng MS, Liu Y, Guo C (2017) Dual-tail approach to discovery of novel carbonic anhydrase IX inhibitors by simultaneously matching the hydrophobic and hydrophilic halves of the active site. Eur J Med Chem 132:1\u201310","journal-title":"Eur J Med Chem"},{"issue":"15","key":"3_CR67","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.1016\/j.bmc.2015.05.019","volume":"23","author":"DA Ibrahim","year":"2015","unstructured":"Ibrahim DA, Lasheen DS, Zaky MY, Ibrahim AW, Vullo D, Ceruso M, Supuran CT, El-Ella DAA (2015) Design and synthesis of benzothiazole-6-sulfonamides acting as highly potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII. Bioorg Med Chem 23(15):4989\u20134999","journal-title":"Bioorg Med Chem"},{"key":"3_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmech.2018.04.016","volume":"152","author":"HS Ibrahim","year":"2018","unstructured":"Ibrahim HS, Allam HA, Mahmoud WR, Bonardi A, Nocentini A, Gratteri P, Ibrahim ES, Abdel-Aziz HA, Supuran CT (2018) Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: selective inhibitors for the tumor-associated hCA IX isoform. Eur J Med Chem 152:1\u20139","journal-title":"Eur J Med Chem"},{"issue":"15","key":"3_CR69","doi-asserted-by":"publisher","first-page":"7424","DOI":"10.1016\/j.bmc.2008.06.013","volume":"16","author":"A Innocenti","year":"2008","unstructured":"Innocenti A, Vullo D, Scozzafava A, Supuran CT (2008) Carbonic anhydrase inhibitors: inhibition of mammalian isoforms I-XIV with a series of substituted phenols including paracetamol and salicylic acid. Bioorg Med Chem 16(15):7424\u20137428","journal-title":"Bioorg Med Chem"},{"issue":"17","key":"3_CR70","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1016\/j.bmcl.2010.07.038","volume":"20","author":"A Innocenti","year":"2010","unstructured":"Innocenti A, G\u00fcl\u00e7in I, Scozzafava A, Supuran CT (2010) Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV. Bioorg Med Chem Lett 20(17):5050\u20135053","journal-title":"Bioorg Med Chem Lett"},{"issue":"6","key":"3_CR71","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/j.bmc.2010.01.076","volume":"18","author":"A Innocenti","year":"2010","unstructured":"Innocenti A, Beyza \u00d6zt\u00fcrk Sar\u0131kaya S, G\u00fcl\u00e7in \u0130, Supuran CT (2010) Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids. Bioorg Med Chem 18(6):2159\u20132164","journal-title":"Bioorg Med Chem"},{"key":"3_CR72","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.bmc.2016.11.045","volume":"25","author":"J Ivanova","year":"2017","unstructured":"Ivanova J, Balode A, \u017dalubovskis R, Leitans J, Kazaks A, Vullo D, Tars K, Supuran CT (2017) 5-Substituted-benzylsulfanyl-thiophene-2-sulfonamides with effective carbonic anhydrase inhibitory activity: solution and crystallographic investigations. Bioorg Med Chem 25:857\u2013863","journal-title":"Bioorg Med Chem"},{"issue":"8","key":"3_CR73","doi-asserted-by":"publisher","first-page":"5703","DOI":"10.1021\/acs.jmedchem.3c00007","volume":"66","author":"JN Ivanova","year":"2023","unstructured":"Ivanova JN, Nocentini A, Tars K, Leitans JN, Dvinskis E, Kazaks A, Domra\u010deva I, Supuran CT, \u017dalubovskis R (2023) Atropo\/Tropo flexibility: a tool for design and synthesis of self-adaptable inhibitors of carbonic anhydrases and their antiproliferative effect. J Med Chem 66(8):5703\u20135718","journal-title":"J Med Chem"},{"key":"3_CR74","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/cmdc.201900703","volume":"15","author":"C Jiang","year":"2020","unstructured":"Jiang C, Shi J, Liao L, Zhang L, Liu J, Wang Y, Lao Y, Zhang J (2020) 5-[2-(N-(Substituted phenyl)acetamide)]amino-1,3,4-thiadiazole-2-sulfonamides as selective carbonic anhydrase II inhibitors with neuroprotective effects. ChemMedChem 15:705\u2013715","journal-title":"ChemMedChem"},{"key":"3_CR75","doi-asserted-by":"publisher","first-page":"9540","DOI":"10.1021\/acs.jmedchem.0c00734","volume":"63","author":"J Kaur","year":"2020","unstructured":"Kaur J, Cao X, Abutaleb NS, Elkashif A, Graboski AL, Krabill AD, AbdelKhalek AH, An W, Bhardwaj A, Seleem MN, Flaherty DP (2020) Optimization of acetazolamide-based scaffold as potent inhibitors of vancomycin-resistant Enterococcus. J Med Chem 63:9540\u20139562","journal-title":"J Med Chem"},{"key":"3_CR76","doi-asserted-by":"publisher","first-page":"5079","DOI":"10.3390\/cancers14205079","volume":"14","author":"M Khan","year":"2022","unstructured":"Khan M, Shah SR, Khan F, Halim SA, Rahman SM, Khalid M, Khan A, Al-Harrasi A (2022) Efficient synthesis with green chemistry approach of novel pharmacophores of imidazole-based hybrids for tumor treatment: mechanistic insights from in situ to in silico. Cancers 14:5079","journal-title":"Cancers"},{"key":"3_CR77","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ejmech.2015.06.022","volume":"101","author":"M Krasavin","year":"2015","unstructured":"Krasavin M, Korsakov M, Dorogov M, Tuccinardi T, Dedeoglu N, Supuran CT (2015) Probing the \u2018bipolar\u2019 nature of the carbonic anhydrase active site: aromatic sulfonamides containing 1,3-oxazol-5-yl moiety as picomolar inhibitors of cytosolic CA I and CA II isoforms. Eur J Med Chem 101:334\u2013347","journal-title":"Eur J Med Chem"},{"key":"3_CR78","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1016\/j.bmc.2017.02.018","volume":"25","author":"M Krasavin","year":"2017","unstructured":"Krasavin M, Korsakov M, Zvonaryova Z, Semyonychev E, Tuccinardi T, Kalinin S, Tan\u00e7 M, Supuran CT (2017) Human carbonic anhydrase inhibitory profile of mono- and bis-sulfonamides synthesized via a direct sulfochlorination of 3- and 4-(hetero)arylisoxazol-5-amine scaffolds. Bioorg Med Chem 25:1914\u20131925","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"3_CR79","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1042\/bj0430525","volume":"43","author":"HA Krebs","year":"1948","unstructured":"Krebs HA (1948) Inhibition of carbonic anhydrase by sulfonamides. Biochem J 43(4):525\u2013528","journal-title":"Biochem J"},{"key":"3_CR80","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.bioorg.2019.03.003","volume":"87","author":"BZ Kurt","year":"2019","unstructured":"Kurt BZ, Dag A, Do\u011fan B, Durdagi S, Angeli A, Nocentini A, Supuran CT, Sonmez F (2019) Synthesis, biological activity and multiscale molecular modeling studies of bis-coumarins as selective carbonic anhydrase IX and XII inhibitors with effective cytotoxicity against hepatocellular carcinoma. Bioorg Chem 87:838\u2013850","journal-title":"Bioorg Chem"},{"issue":"6","key":"3_CR81","doi-asserted-by":"publisher","first-page":"5787","DOI":"10.1021\/acsomega.2c07459","volume":"8","author":"BZ Kurt","year":"2023","unstructured":"Kurt BZ, Celebi G, Ozturk Civelek D, Angeli A, Akdemir A, Sonmez F, Supuran CT (2023) Tail-approach-based design and synthesis of coumarin-monoterpenes as carbonic anhydrase inhibitors and anticancer agents. ACS Omega 8(6):5787\u20135807","journal-title":"ACS Omega"},{"issue":"8","key":"3_CR82","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1021\/acsmedchemlett.9b00252","volume":"10","author":"A Larcher","year":"2019","unstructured":"Larcher A, Nocentini A, Supuran CT, Winum JY, van der Lee A, Vasseur JJ, Laurencin D, Smietana M (2019) Bis-benzoxaboroles: design, synthesis, and biological evaluation as carbonic anhydrase inhibitors. ACS Med Chem Lett 10(8):1205\u20131210","journal-title":"ACS Med Chem Lett"},{"key":"3_CR83","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.1016\/j.bmc.2013.06.041","volume":"21","author":"J Leitans","year":"2013","unstructured":"Leitans J, Sprudza A, Tan\u00e7 M, Vozny I, Zalubovskis R, Tars K, Supuran CT (2013) 5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies. Bioorg Med Chem 21:5130\u20135138","journal-title":"Bioorg Med Chem"},{"issue":"9","key":"3_CR84","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1080\/10426500701407755","volume":"182","author":"H Loghmani-Khouzani","year":"2007","unstructured":"Loghmani-Khouzani H, Rauckyte T, O\u015bmia\u0142owski B, Gawinecki R, Kolehmainen E (2007) GIAO\/DFT 13C NMR chemical shifts of 1,3,4-thiadiazoles. Phosphorus Sulfur Silicon Relat Elem 182(9):2217\u20132225","journal-title":"Phosphorus Sulfur Silicon Relat Elem"},{"issue":"5","key":"3_CR85","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.bmc.2016.01.019","volume":"24","author":"CL Lomelino","year":"2016","unstructured":"Lomelino CL, Mahon BP, McKenna R, Carta F, Supuran CT (2016) Kinetic and X-ray crystallographic investigations on carbonic anhydrase isoforms I, II, IX and XII of a thioureido analog of SLC-0111. Bioorg Med Chem 24(5):976\u2013981","journal-title":"Bioorg Med Chem"},{"issue":"7","key":"3_CR86","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1021\/jm2000213","volume":"54","author":"P Mader","year":"2011","unstructured":"Mader P, Brynda J, Gitto R, Agnello S, Pachl P, Supuran CT, Chimirri A, \u0158ez\u00e1\u010dov\u00e1 P (2011) Structural basis for the interaction between carbonic anhydrase and 1,2,3,4-tetrahydroisoquinolin-2-ylsulfonamides. J Med Chem 54(7):2522\u20132526","journal-title":"J Med Chem"},{"key":"3_CR87","first-page":"425","volume":"90","author":"TH Maren","year":"2000","unstructured":"Maren TH (2000) Carbonic anhydrase inhibition in ophthalmology: aqueous humor secretion and the development of sulfonamide inhibitors. EXS 90:425\u2013435","journal-title":"EXS"},{"issue":"8","key":"3_CR88","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1021\/ja809683v","volume":"131","author":"A Maresca","year":"2009","unstructured":"Maresca A, Temperini C, Vu H, Pham NB, Poulsen SA, Scozzafava A, Quinn RJ, Supuran CT (2009) Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors. J Am Chem Soc 131(8):3057\u20133062","journal-title":"J Am Chem Soc"},{"issue":"1","key":"3_CR89","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1021\/jm901287j","volume":"53","author":"A Maresca","year":"2010","unstructured":"Maresca A, Temperini C, Pochet L, Masereel B, Scozzafava A, Supuran CT (2010) Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins. J Med Chem 53(1):335\u2013344","journal-title":"J Med Chem"},{"issue":"15","key":"3_CR90","doi-asserted-by":"publisher","first-page":"4511","DOI":"10.1016\/j.bmcl.2010.06.040","volume":"20","author":"A Maresca","year":"2010","unstructured":"Maresca A, Supuran CT (2010) Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II. Bioorg Med Chem Lett 20(15):4511\u20134514","journal-title":"Bioorg Med Chem Lett"},{"issue":"21","key":"3_CR91","doi-asserted-by":"publisher","first-page":"19077","DOI":"10.1021\/acs.jmedchem.4c01555","volume":"67","author":"B Marinacci","year":"2024","unstructured":"Marinacci B, D\u2019Agostino I, Angeli A, Carradori S, Melfi F, Grande R, Corsiani M, Ferraroni M, Agamennone M, Tondo AR, Zara S, Puca V, Pellegrini B, Vagaggini C, Dreassi E, Patrauchan MA, Capasso C, Nicolotti O, Carta F, Supuran CT (2024) Inhibition of Pseudomonas aeruginosa carbonic anhydrases, exploring ciprofloxacin functionalization toward new antibacterial agents: an in-depth multidisciplinary study. J Med Chem 67(21):19077\u201319102","journal-title":"J Med Chem"},{"issue":"2","key":"3_CR92","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1021\/jm0109199","volume":"45","author":"B Masereel","year":"2002","unstructured":"Masereel B, Rolin S, Abbate F, Scozzafava A, Supuran CT (2002) Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties. J Med Chem 45(2):312\u2013320","journal-title":"J Med Chem"},{"key":"3_CR93","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ejmech.2017.03.026","volume":"132","author":"MY Mboge","year":"2017","unstructured":"Mboge MY, Mahon BP, Lamas N, Socorro L, Carta F, Supuran CT, Frost SC, McKenna R (2017) Structure-activity study of carbonic anhydrase IX: selective inhibition with ureido-substituted benzenesulfonamides. Eur J Med Chem 132:184\u2013191","journal-title":"Eur J Med Chem"},{"key":"3_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2025.126820","volume":"345","author":"F Meletli","year":"2025","unstructured":"Meletli F, Mutafo\u011flu BS, \u00d6zdemir M, Yal\u00e7\u0131n B, Dan\u0131\u015f \u00d6, Demir S (2025) Synthesis of 7-hydroxy coumarin derivatives and interaction with bovine serum albumin by multi-spectroscopic studies and molecular docking. Spectrochim Acta A Mol Biomol Spectrosc 345:126820","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"issue":"7","key":"3_CR95","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1021\/acsmedchemlett.8b00170","volume":"9","author":"C Melis","year":"2018","unstructured":"Melis C, Distinto S, Bianco G, Meleddu R, Cottiglia F, Fois B, Taverna D, Angius R, Alcaro S, Ortuso F, Gaspari M, Angeli A, Del Prete S, Capasso C, Supuran CT, Maccioni E (2018) Targeting tumor associated carbonic anhydrases IX and XII: highly isozyme selective coumarin and psoralen inhibitors. ACS Med Chem Lett 9(7):725\u2013729","journal-title":"ACS Med Chem Lett"},{"key":"3_CR96","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1021\/jm050333c","volume":"48","author":"V Menchise","year":"2005","unstructured":"Menchise V, De Simone G, Alterio V, Di Fiore A, Pedone C, Scozzafava A, Supuran CT (2005) Carbonic anhydrase inhibitors: stacking with Phe131 determines active site binding region of inhibitors as exemplified by the X-ray crystal structure of a membrane-impermeant antitumor sulfonamide complexed with isozyme II. J Med Chem 48:5721\u20135727","journal-title":"J Med Chem"},{"issue":"23","key":"3_CR97","doi-asserted-by":"publisher","first-page":"25485","DOI":"10.1021\/acs.jmedchem.5c02626","volume":"68","author":"L Micheli","year":"2025","unstructured":"Micheli L, Angeli A, Mannelli LDC, Ghelardini C, Ferraroni M, Barons R, Zalubovskis R, Zara S, Carradori S, Supuran CT (2025) Targeting human carbonic anhydrases with novel piperazine and homopiperazine benzenesulfonamides to alleviate paclitaxel-induced peripheral neuropathy. J Med Chem 68(23):25485\u201325504","journal-title":"J Med Chem"},{"key":"3_CR98","doi-asserted-by":"publisher","first-page":"4893","DOI":"10.1021\/ja01167a012","volume":"72","author":"WH Miller","year":"1950","unstructured":"Miller WH, Dessert AM, Roblin RO Jr (1950) Heterocyclic sulfonamides as carbonic anhydrase inhibitors. J Am Chem Soc 72:4893","journal-title":"J Am Chem Soc"},{"issue":"8","key":"3_CR99","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1021\/jm500255y","volume":"57","author":"J Moeker","year":"2014","unstructured":"Moeker J, Peat TS, Bornaghi LF, Vullo D, Supuran CT, Poulsen SA (2014) Cyclic secondary sulfonamides: unusually good inhibitors of cancer-related carbonic anhydrase enzymes. J Med Chem 57(8):3522\u20133531","journal-title":"J Med Chem"},{"issue":"1","key":"3_CR100","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/14756366.2017.1413097","volume":"33","author":"SM Monti","year":"2018","unstructured":"Monti SM, Meccariello A, Ceruso M, Szafra\u0144ski K, S\u0142awi\u0144ski J, Supuran CT (2018) Inhibition studies of Brucella suis \u03b2-carbonic anhydrases with a series of 4-substituted pyridine-3-sulfonamides. J Enzyme Inhib Med Chem 33(1):255\u2013259","journal-title":"J Enzyme Inhib Med Chem"},{"key":"3_CR101","doi-asserted-by":"publisher","first-page":"6905","DOI":"10.1021\/jm200892s","volume":"54","author":"JC Morris","year":"2011","unstructured":"Morris JC, Chiche J, Grellier C, Lopez M, Bornaghi LF, Maresca A, Supuran CT, Pouyss\u00e9gur J, Poulsen SA (2011) Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors. J Med Chem 54:6905\u20136918","journal-title":"J Med Chem"},{"key":"3_CR102","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.1021\/ja00087a086","volume":"116","author":"SK Nair","year":"1994","unstructured":"Nair SK, Ludwig PA, Christianson DW (1994) Two-site binding of phenol in the active site of human carbonic anhydrase II: structural implications for substrate association. J Am Chem Soc 116:3659\u20133660","journal-title":"J Am Chem Soc"},{"issue":"10","key":"3_CR103","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nrd3554","volume":"10","author":"D Neri","year":"2011","unstructured":"Neri D, Supuran CT (2011) Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 10(10):767\u2013777","journal-title":"Nat Rev Drug Discov"},{"issue":"21","key":"3_CR104","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.1016\/j.bmc.2015.09.041","volume":"23","author":"A Nocentini","year":"2015","unstructured":"Nocentini A, Carta F, Ceruso M, Bartolucci G, Supuran CT (2015) Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII. Bioorg Med Chem 23(21):6955\u20136966","journal-title":"Bioorg Med Chem"},{"key":"3_CR105","doi-asserted-by":"publisher","first-page":"10692","DOI":"10.1021\/acs.jmedchem.6b01389","volume":"59","author":"A Nocentini","year":"2016","unstructured":"Nocentini A, Ferraroni M, Carta F, Ceruso M, Gratteri P, Lanzi C, Masini E, Supuran CT (2016) Benzenesulfonamides incorporating flexible triazole moieties are highly effective carbonic anhydrase inhibitors: synthesis and kinetic, crystallographic, computational, and intraocular pressure lowering investigations. J Med Chem 59:10692\u201310704","journal-title":"J Med Chem"},{"issue":"6","key":"3_CR106","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3109\/14756366.2015.1115401","volume":"31","author":"A Nocentini","year":"2016","unstructured":"Nocentini A, Ceruso M, Carta F, Supuran CT (2016) 7-Aryl-triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrase IX and XII. J Enzyme Inhib Med Chem 31(6):1226\u20131233","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"12","key":"3_CR107","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1021\/acsmedchemlett.7b00399","volume":"8","author":"A Nocentini","year":"2017","unstructured":"Nocentini A, Bua S, Lomelino CL, McKenna R, Menicatti M, Bartolucci G, Tenci B, Di Cesare Mannelli L, Ghelardini C, Gratteri P, Supuran CT (2017) Discovery of new sulfonamide carbonic anhydrase IX inhibitors incorporating nitrogenous bases. ACS Med Chem Lett 8(12):1314\u20131319","journal-title":"ACS Med Chem Lett"},{"key":"3_CR108","doi-asserted-by":"publisher","first-page":"10860","DOI":"10.1021\/acs.jmedchem.8b01504","volume":"61","author":"A Nocentini","year":"2018","unstructured":"Nocentini A, Trallori E, Singh S, Lomelino CL, Bartolucci G, Di Cesare Mannelli L, Ghelardini C, McKenna R, Gratteri P, Supuran CT (2018) 4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms IX and XII showing hypoxia-enhanced antiproliferative profiles. J Med Chem 61:10860\u201310874","journal-title":"J Med Chem"},{"issue":"12","key":"3_CR109","doi-asserted-by":"publisher","first-page":"5380","DOI":"10.1021\/acs.jmedchem.8b00625","volume":"61","author":"A Nocentini","year":"2018","unstructured":"Nocentini A, Ceruso M, Bua S, Lomelino CL, Andring JT, McKenna R, Lanzi C, Sgambellone S, Pecori R, Matucci R, Filippi L, Gratteri P, Carta F, Masini E, Selleri S, Supuran CT (2018) Discovery of \u03b2-adrenergic receptors blocker\u2013carbonic anhydrase inhibitor hybrids for multitargeted antiglaucoma therapy. J Med Chem 61(12):5380\u20135394","journal-title":"J Med Chem"},{"issue":"10","key":"3_CR110","doi-asserted-by":"publisher","first-page":"5185","DOI":"10.1021\/acs.jmedchem.9b02135","volume":"63","author":"A Nocentini","year":"2020","unstructured":"Nocentini A, Alterio V, Bua S, Micheli L, Esposito D, Buonanno M, Bartolucci G, Osman SM, AlOthman ZA, Cirilli R, Pierini M, Monti SM, Di Cesare Mannelli L, Gratteri P, Ghelardini C, De Simone G, Supuran CT (2020) Phenyl(thio)phosphon(amid)ate benzenesulfonamides as potent and selective inhibitors of human carbonic anhydrases II and VII counteract allodynia in a mouse model of oxaliplatin-induced neuropathy. J Med Chem 63(10):5185\u20135200","journal-title":"J Med Chem"},{"issue":"12","key":"3_CR111","doi-asserted-by":"publisher","first-page":"8118","DOI":"10.1021\/acs.jmedchem.3c00433","volume":"66","author":"A Nocentini","year":"2023","unstructured":"Nocentini A, Bonardi A, Bazzicalupi C, Alterio V, Esposito D, Monti SM, Smietana M, De Simone G, Supuran CT, Gratteri P, Winum JY (2023) 6-Substituted triazolyl benzoxaboroles as selective carbonic anhydrase inhibitors: in silico design, synthesis, and X-ray crystallography. J Med Chem 66(12):8118\u20138129","journal-title":"J Med Chem"},{"issue":"1","key":"3_CR112","doi-asserted-by":"publisher","first-page":"2366236","DOI":"10.1080\/14756366.2024.2366236","volume":"39","author":"A Nocentini","year":"2024","unstructured":"Nocentini A, Di Porzio A, Bonardi A, Bazzicalupi C, Petreni A, Biver T, Bua S, Marzano S, Amato J, Pagano B, Iaccarino N, De Tito S, Amente S, Supuran CT, Randazzo A, Gratteri P (2024) Development of a multi-targeted chemotherapeutic approach based on G-quadruplex stabilisation and carbonic anhydrase inhibition. J Enzyme Inhib Med Chem 39(1):2366236","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"4","key":"3_CR113","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1021\/acs.jmedchem.2c01843","volume":"66","author":"CB O\u2019Herin","year":"2023","unstructured":"O\u2019Herin CB, Moriuchi YW, Bemis TA, Kohlbrand AJ, Burkart MD, Cohen SM (2023) Development of human carbonic anhydrase II heterobifunctional degraders. J Med Chem 66(4):2789\u20132803","journal-title":"J Med Chem"},{"key":"3_CR114","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1021\/jm101541x","volume":"54","author":"F Pacchiano","year":"2011","unstructured":"Pacchiano F, Carta F, McDonald PC, Lou Y, Vullo D, Scozzafava A, Dedhar S, Supuran CT (2011) Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis. J Med Chem 54:1896\u20131902","journal-title":"J Med Chem"},{"issue":"4","key":"3_CR115","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.bmcl.2003.12.029","volume":"14","author":"S Pastorekova","year":"2004","unstructured":"Pastorekova S, Casini A, Scozzafava A, Vullo D, Pastorek J, Supuran CT (2004) Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX. Bioorg Med Chem Lett 14(4):869\u2013873","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"3_CR116","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/molecules23010153","volume":"23","author":"A Peperidou","year":"2018","unstructured":"Peperidou A, Bua S, Bozdag M, Hadjipavlou-Litina D, Supuran CT (2018) Novel 6- and 7-substituted coumarins with inhibitory action against lipoxygenase and tumor-associated carbonic anhydrase IX. Molecules 23(1):153","journal-title":"Molecules"},{"key":"3_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108857","volume":"164","author":"D Pratesi","year":"2025","unstructured":"Pratesi D, Brenzini Biagioni F, Matassini C, Cardona F, Angeli A, Bonardi A, Gratteri P, Supuran CT, Goti A (2025) Studies on Azasugar-based sulfonamides: a new class of carbonic anhydrase inhibitors. Bioorg Chem 164:108857","journal-title":"Bioorg Chem"},{"key":"3_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115180","volume":"250","author":"MA Ragab","year":"2023","unstructured":"Ragab MA, Eldehna WM, Nocentini A, Bonardi A, Okda HE, Elgendy B, Ibrahim TS, Abd-Alhaseeb MM, Gratteri P, Supuran CT, Al-Karmalawy AA, Elagawany M (2023) 4-(5-Amino-pyrazol-1-yl)benzenesulfonamide derivatives as novel multi-target anti-inflammatory agents endowed with inhibitory activity against COX-2, 5-LOX and carbonic anhydrase: design, synthesis, and biological assessments. Eur J Med Chem 250:115180","journal-title":"Eur J Med Chem"},{"key":"3_CR119","doi-asserted-by":"publisher","first-page":"4890","DOI":"10.1021\/ja01167a011","volume":"72","author":"RO Roblin Jr","year":"1950","unstructured":"Roblin RO Jr, Clapp JW (1950) The preparation of heterocyclic sulfonamides. J Am Chem Soc 72:4890","journal-title":"J Am Chem Soc"},{"issue":"18","key":"3_CR120","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.2174\/0118715206373602250318062414","volume":"25","author":"R Romagnoli","year":"2025","unstructured":"Romagnoli R, Romagnoli E, Brancale A, Supuran CT, Nocentini A, Manfreda L, Zanolli A, Bortolozzi R, Viola G (2025) Design and synthesis of 2-substituted [1,2,4]triazolo[1,5-a]pyrimidines tethered with umbelliferone as selective carbonic anhydrase IX and XII inhibitors. Anti Cancer Agents Med Chem 25(18):1429\u20131446","journal-title":"Anti Cancer Agents Med Chem"},{"key":"3_CR121","doi-asserted-by":"publisher","unstructured":"Roshdy E, \u0158ezn\u00ed\u010dkov\u00e1 E, Elbadawi MM, Celik I, Giovannuzzi S, Vesel\u00e1 D, Veronika Voj\u00e1\u010dkov\u00e1 V, Petra Kr\u0148\u00e1vkov\u00e1 P, Alessio Nocentini A, Claudiu T Supuran CT, Vladim\u00edr Kry\u0161tof V, Wagdy M Eldehna WM, Manabu Abe M (2026) First-in-class dual PDGFR\/carbonic anhydrase IX\/XII inhibitors: 6, 7-dimethoxyquinoline-sulfonamides as promising antileukemic agents. J Med Chem (in press). https:\/\/doi.org\/10.1021\/acs.jmedchem.5c03037","DOI":"10.1021\/acs.jmedchem.5c03037"},{"key":"3_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111843","volume":"185","author":"MA Said","year":"2020","unstructured":"Said MA, Eldehna WM, Nocentini A, Bonardi A, Fahim SH, Bua S, Soliman DH, Abdel-Aziz HA, Gratteri P, Abou-Seri SM, Supuran CT (2020) Synthesis, biological and molecular dynamics investigations with a series of triazolopyrimidine\/triazole-based benzenesulfonamides as novel carbonic anhydrase inhibitors. Eur J Med Chem 185:111843","journal-title":"Eur J Med Chem"},{"key":"3_CR123","doi-asserted-by":"crossref","unstructured":"Saied S, Shaldam M, Elbadawi MM, Giovannuzzi S, Nocentini A, Almahli H, Salem R, Ibrahim TM, Supuran CT, Eldehna WM (2003) Discovery of indolinone-bearing benzenesulfonamides as new dual carbonic anhydrase and VEGFR-2 inhibitors possessing anticancer and pro-apoptotic properties. Eur J Med Chem 259:115707","DOI":"10.1016\/j.ejmech.2023.115707"},{"key":"3_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113490","volume":"220","author":"S Salerno","year":"2021","unstructured":"Salerno S, Amendola G, Angeli A, Baglini E, Barresi E, Marini AM, Ravichandran R, Viviano M, Castellano S, Novellino E, Da Settimo FD, Supuran CT, Cosconati S, Taliani S (2021) Inhibition studies on carbonic anhydrase isoforms I, II, IV and IX with N-arylsubstituted secondary sulfonamides featuring a bicyclic tetrahydroindazole scaffold. Eur J Med Chem 220:113490","journal-title":"Eur J Med Chem"},{"key":"3_CR125","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1021\/jm990479+","volume":"43","author":"A Scozzafava","year":"2000","unstructured":"Scozzafava A, Briganti F, Ilies MA, Supuran CT (2000) Carbonic anhydrase inhibitors: synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes. J Med Chem 43:292\u2013300","journal-title":"J Med Chem"},{"key":"3_CR126","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1021\/jm9900523","volume":"42","author":"A Scozzafava","year":"1999","unstructured":"Scozzafava A, Menabuoni L, Mincione F, Briganti F, Mincione G, Supuran CT (1999) Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic\/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring? J Med Chem 42:2641\u20132650","journal-title":"J Med Chem"},{"issue":"20","key":"3_CR127","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1021\/jm000027t","volume":"43","author":"A Scozzafava","year":"2000","unstructured":"Scozzafava A, Supuran CT (2000) Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes. J Med Chem 43(20):3677\u20133687","journal-title":"J Med Chem"},{"issue":"12","key":"3_CR128","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.3390\/molecules21121726","volume":"21","author":"A Scozzafava","year":"2016","unstructured":"Scozzafava A, Supuran CT, Carta F (2016) Polyamines and \u03b1-carbonic anhydrases. Molecules 21(12):1726","journal-title":"Molecules"},{"key":"3_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.104647","volume":"108","author":"P Singh","year":"2021","unstructured":"Singh P, Yadav PP, Swain B, Thacker PS, Angeli A, Supuran CT, Arifuddin M (2021) Discovery of a novel series of indolylchalcone-benzenesulfonamide hybrids acting as selective carbonic anhydrase II inhibitors. Bioorg Chem 108:104647","journal-title":"Bioorg Chem"},{"key":"3_CR130","volume-title":"Strategies for the synthesis of heterocycles and their applications","author":"D Sharma","year":"2023","unstructured":"Sharma D, Dhayalan V, Manikandan C, Dandela R (2023) Recent methods for synthesis of coumarin derivatives and their new applications. In: Strategies for the synthesis of heterocycles and their applications. IntechOpen"},{"key":"3_CR131","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ejmech.2013.09.027","volume":"69","author":"J S\u0142awi\u0144ski","year":"2013","unstructured":"S\u0142awi\u0144ski J, Szafra\u0144ski K, Vullo D, Supuran CT (2013) Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII. Eur J Med Chem 69:701","journal-title":"Eur J Med Chem"},{"issue":"9","key":"3_CR132","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S0223-5234(00)00169-0","volume":"35","author":"CT Supuran","year":"2000","unstructured":"Supuran CT, Scozzafava A (2000) Carbonic anhydrase inhibitors\u2013Part 94. 1,3,4-thiadiazole-2-sulfonamidederivatives as antitumor agents. Eur J Med Chem 35(9):867","journal-title":"Eur J Med Chem"},{"issue":"4","key":"3_CR133","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/14756360009040695","volume":"15","author":"CT Supuran","year":"2000","unstructured":"Supuran CT, Scozzafava A, Ilies MA, Briganti F (2000) Carbonic anhydrase inhibitors: synthesis of sulfonamides incorporating 2,4,6-trisubstituted-pyridinium-ethylcarboxamido moieties possessing membrane-impermeability and in vivo selectivity for the membrane-bound (CA IV) versus the cytosolic (CA I and CA II) isozymes. J Enzym Inhib 15(4):381\u2013401","journal-title":"J Enzym Inhib"},{"issue":"2","key":"3_CR134","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/med.10025","volume":"23","author":"CT Supuran","year":"2003","unstructured":"Supuran CT, Scozzafava A, Casini A (2003) Carbonic anhydrase inhibitors. Med Res Rev 23(2):146\u2013189","journal-title":"Med Res Rev"},{"issue":"13","key":"3_CR135","doi-asserted-by":"publisher","first-page":"4336","DOI":"10.1016\/j.bmc.2007.04.020","volume":"15","author":"CT Supuran","year":"2007","unstructured":"Supuran CT, Scozzafava A (2007) Carbonic anhydrases as targets for medicinal chemistry. Bioorg Med Chem 15(13):4336\u20134350","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"3_CR136","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrd2467","volume":"7","author":"CT Supuran","year":"2008","unstructured":"Supuran CT (2008) Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 7(2):168\u2013181","journal-title":"Nat Rev Drug Discov"},{"issue":"14","key":"3_CR137","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1042\/BCJ20160115","volume":"473","author":"CT Supuran","year":"2016","unstructured":"Supuran CT (2016) Structure and function of carbonic anhydrases. Biochem J 473(14):2023\u20132032","journal-title":"Biochem J"},{"issue":"1","key":"3_CR138","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/17460441.2017.1253677","volume":"12","author":"CT Supuran","year":"2017","unstructured":"Supuran CT (2017) Advances in structure-based drug discovery of carbonic anhydrase inhibitors. Expert Opin Drug Discov 12(1):61\u201388","journal-title":"Expert Opin Drug Discov"},{"issue":"1","key":"3_CR139","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1080\/14756366.2020.1788009","volume":"35","author":"CT Supuran","year":"2020","unstructured":"Supuran CT (2020) Coumarin carbonic anhydrase inhibitors from natural sources. J Enzyme Inhib Med Chem 35(1):1462\u20131470","journal-title":"J Enzyme Inhib Med Chem"},{"key":"3_CR140","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1080\/14756366.2020.1788009","volume":"35","author":"CT Supuran","year":"2020","unstructured":"Supuran CT (2020) Non-classical carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 35:170\u2013180","journal-title":"J Enzyme Inhib Med Chem"},{"key":"3_CR141","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1042\/CS20210040","volume":"135","author":"CT Supuran","year":"2021","unstructured":"Supuran CT (2021) Emerging role of carbonic anhydrase inhibitors. Clin Sci 135:1233\u20131249","journal-title":"Clin Sci"},{"issue":"11","key":"3_CR142","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3390\/md20110721","volume":"20","author":"CT Supuran","year":"2022","unstructured":"Supuran CT (2022) Carbonic anhydrase inhibitors from marine natural products. Mar Drugs 20(11):721","journal-title":"Mar Drugs"},{"issue":"1","key":"3_CR143","doi-asserted-by":"publisher","DOI":"10.1124\/pharmrev.124.001125","volume":"77","author":"CT Supuran","year":"2025","unstructured":"Supuran CT (2025) Multi- and polypharmacology of carbonic anhydrase inhibitors. Pharmacol Rev 77(1):100004","journal-title":"Pharmacol Rev"},{"issue":"10","key":"3_CR144","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1021\/acsmedchemlett.5c00443","volume":"16","author":"CT Supuran","year":"2025","unstructured":"Supuran CT (2025) Human carbonic anhydrase inhibitors. ACS Med Chem Lett 16(10):1889\u20131895","journal-title":"ACS Med Chem Lett"},{"issue":"1","key":"3_CR145","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1039\/C4OB02155J","volume":"13","author":"M Tanc","year":"2015","unstructured":"Tanc M, Carta F, Scozzafava A, Supuran CT (2015) 6-Substituted 1,2-benzoxathiine-2,2-dioxides are isoform-selective inhibitors of human carbonic anhydrases IX, XII and VA. Org Biomol Chem 13(1):77\u201380","journal-title":"Org Biomol Chem"},{"key":"3_CR146","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1021\/jm501798g","volume":"58","author":"RP Tanpure","year":"2015","unstructured":"Tanpure RP, Ren B, Peat TS, Bornaghi LF, Vullo D, Supuran CT, Poulsen SA (2015) Carbonic anhydrase inhibitors with dual-tail moieties to match the hydrophobic and hydrophilic halves of the carbonic anhydrase active site. J Med Chem 58:1494\u20131501","journal-title":"J Med Chem"},{"issue":"1","key":"3_CR147","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1021\/jm301625s","volume":"56","author":"K Tars","year":"2013","unstructured":"Tars K, Vullo D, Kazaks A, Leitans J, Lends A, Grandane A, Zalubovskis R, Scozzafava A, Supuran CT (2013) Sulfocoumarins (1,2-benzoxathiine-2,2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases. J Med Chem 56(1):293\u2013300","journal-title":"J Med Chem"},{"key":"3_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114190","volume":"232","author":"HO Tawfik","year":"2022","unstructured":"Tawfik HO, Petreni A, Supuran CT, El-Hamamsy MH (2022) Discovery of new carbonic anhydrase IX inhibitors as anticancer agents by toning the hydrophobic and hydrophilic rims of the active site to encounter the dual-tail approach. Eur J Med Chem 232:114190","journal-title":"Eur J Med Chem"},{"key":"3_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2025.102181","volume":"15","author":"IT Tchoupou","year":"2025","unstructured":"Tchoupou IT, Manyeruke MH, Salami SA, Ezekiel CI, Ambassa P, Tembu JV, Krause RWM, Ngameni B, Noundou XS (2025) An overview of the synthesis of coumarins via Knoevenagel condensation and their biological properties. Results Chem 15:102181","journal-title":"Results Chem"},{"key":"3_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.115011","volume":"246","author":"A Tinivella","year":"2023","unstructured":"Tinivella A, Nwachukwu JC, Angeli A, Foschi F, Benatti AL, Pinzi L, Izard T, Ferraroni M, Erumbi R, Christodoulou MS, Passarella D, Supuran CT, Nettles KW, Rastelli G (2023) Design, synthesis, biological evaluation and crystal structure determination of dual modulators of carbonic anhydrases and estrogen receptors. Eur J Med Chem 246:115011","journal-title":"Eur J Med Chem"},{"key":"3_CR151","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202204191","volume":"8","author":"SF Tokali","year":"2023","unstructured":"Tokali SF, Alim Z, Yirtici U (2023) Carboxylate- and sulfonate-containing quinazolin-4(3H)-one rings: synthesis, characterization, and carbonic anhydrase I\u2013II and acetylcholinesterase inhibition properties. ChemistrySelect 8:e202204191","journal-title":"ChemistrySelect"},{"issue":"9","key":"3_CR152","doi-asserted-by":"publisher","first-page":"13093","DOI":"10.3390\/molecules190913093","volume":"19","author":"V Vahabi","year":"2014","unstructured":"Vahabi V, Hatamjafari F (2014) Microwave-assisted convenient one-pot synthesis of coumarin derivatives via Pechmann condensation catalyzed by FeF3 under solvent-free conditions and antimicrobial activities of the products. Molecules 19(9):13093\u201313103","journal-title":"Molecules"},{"issue":"3","key":"3_CR153","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/jps.2600730316","volume":"73","author":"A Vedani","year":"1984","unstructured":"Vedani A, Meyer EF Jr (1984) Structure\u2013activity relationships of sulfonamide drugs and human carbonic anhydrase C: modeling of inhibitor molecules into the receptor site of the enzyme with an interactive computer graphics display. J Pharm Sci 73(3):352\u2013358","journal-title":"J Pharm Sci"},{"key":"3_CR154","unstructured":"Welichem Biotech Inc (2016) Safety study of SLC-0111 in subjects with advanced solid tumours. ClinicalTrials.gov identifier: NCT02215850. Available at: https:\/\/clinicaltrials.gov\/study\/NCT02215850"},{"key":"3_CR155","doi-asserted-by":"publisher","first-page":"6539","DOI":"10.1021\/jm060967z","volume":"49","author":"BL Wilkinson","year":"2006","unstructured":"Wilkinson BL, Bornaghi LF, Houston TA, Innocenti A, Supuran CT, Poulsen SA (2006) A novel class of carbonic anhydrase inhibitors: glycoconjugate benzene sulfonamides prepared by \u201cclick-tailing\u201d. J Med Chem 49:6539\u20136548","journal-title":"J Med Chem"},{"key":"3_CR156","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/med.20141","volume":"29","author":"JY Winum","year":"2009","unstructured":"Winum JY, Poulsen SA, Supuran CT (2009) Therapeutic applications of glycosidic carbonic anhydrase inhibitors. Med Res Rev 29:419\u2013435","journal-title":"Med Res Rev"},{"key":"3_CR157","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.bmc.2012.10.043","volume":"21","author":"JY Winum","year":"2013","unstructured":"Winum JY, Colinas PA, Supuran CT (2013) Glycosidic carbonic anhydrase IX inhibitors: a sweet approach against cancer. Bioorg Med Chem 21:1419\u20131426","journal-title":"Bioorg Med Chem"},{"issue":"17","key":"3_CR158","doi-asserted-by":"publisher","first-page":"15537","DOI":"10.1021\/acs.jmedchem.4c01187","volume":"67","author":"MS Youse","year":"2024","unstructured":"Youse MS, Abutaleb NS, Nocentini A, Abdelsattar AS, Ali F, Supuran CT, Seleem MN, Flaherty DP (2024) Optimization of ethoxzolamide analogs with improved pharmacokinetic properties for in vivo efficacy against Neisseria gonorrhoeae. J Med Chem 67(17):15537\u201315556","journal-title":"J Med Chem"},{"issue":"4","key":"3_CR159","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/14756360600741503","volume":"21","author":"M Zareef","year":"2006","unstructured":"Zareef M, Innocenti A, Iqbal R, Zaidi JH, Arfan M, Scozzafava A, Supuran CT (2006) Carbonic anhydrase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozymes I and II with some 1,3,4-oxadiazole-thiols. J Enzyme Inhib Med Chem 21(4):351\u2013359","journal-title":"J Enzyme Inhib Med Chem"},{"key":"3_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113300","volume":"216","author":"B Zhang","year":"2021","unstructured":"Zhang B, Liu Z, Xia S, Liu Q, Gou S (2021) Design, synthesis and biological evaluation of sulfamoylphenyl-quinazoline derivatives as potential EGFR\/CAIX dual inhibitors. Eur J Med Chem 216:113300","journal-title":"Eur J Med Chem"}],"container-title":["Subcellular Biochemistry","Carbonic Anhydrase Inhibitors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-23172-7_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:12:27Z","timestamp":1777597947000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-032-23172-7_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032231710","9783032231727"],"references-count":160,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-23172-7_3","relation":{},"ISSN":["0306-0225","2542-8810"],"issn-type":[{"value":"0306-0225","type":"print"},{"value":"2542-8810","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 May 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}